Basic/Clinical Science Session
Generating Evidence to Advance Care for Children with Kidney Diseases
October 23, 2026 | 04:30 PM - 06:00 PM
Location: Room 107, Convention Center
Session Description
Progress in pediatric CKD is limited by small patient populations, fragmented trial infrastructure, and uncertainty about meaningful end points. This session highlights strategies to advance the field by centering patient and family engagement, leveraging pediatric trial networks, and grounding surrogate end points in biological plausibility. Through expert talks and a moderated panel, participants explore practical approaches to designing feasible, ethical, and patient-centered pediatric CKD trials.
Learning Objective(s)
- Explain why patient and family engagement is essential to advancing pediatric CKD research and clinical trials
- Describe the role of pediatric trial networks in overcoming barriers to CKD clinical research
- Evaluate the strengths and limitations of potential surrogate end points, using Alport syndrome as a case example
- Identify actionable strategies to improve design, conduct, and participation in pediatric CKD trials
Learning Pathway(s)
- Pediatric Nephrology
- CKD Non-Dialysis
Moderators
Presentations
- Patient and Family Engagement Is Critical to Move the Field Forward
04:30 PM - 04:55 PM
- Pediatric Trial Networks in CKD: A Much-Needed Advance
04:55 PM - 05:20 PM
- Biological Plausibility of Potential Surrogate End Points: Case Example in Alport Syndrome
05:20 PM - 05:45 PM
- Panel Discussion: How Can We Do Better in Pediatric Trials?
05:45 PM - 06:00 PM